{
    "2019-09-30": [
        [
            {
                "time": "",
                "original_text": "国家组织药品集中采购和使用试点将在全国推开，这些医药股已站在风口",
                "features": {
                    "keywords": [
                        "药品集中采购",
                        "使用试点",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "2019年医药三季报业绩前瞻||三季报预期向好，关注“变化”、稳守“核心资产”【兴证医药】",
                "features": {
                    "keywords": [
                        "医药",
                        "三季报",
                        "业绩",
                        "核心资产"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国民经济70年“领头雁”：混改为国企改革突破口",
                "features": {
                    "keywords": [
                        "国企改革",
                        "混改",
                        "国民经济"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报:带量采购扩面落地,转型创新不二选择",
                "features": {
                    "keywords": [
                        "医药行业",
                        "带量采购",
                        "转型创新"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}